These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Melanoma. Benson C; Gore ME Cancer Chemother Biol Response Modif; 2001; 19():629-38. PubMed ID: 11686036 [No Abstract] [Full Text] [Related]
4. Leveraging the activity of tumor vaccines with cytotoxic chemotherapy. Emens LA; Jaffee EM Cancer Res; 2005 Sep; 65(18):8059-64. PubMed ID: 16166275 [TBL] [Abstract][Full Text] [Related]
5. IV. Genes, cells, drugs. Cures for the future. Can we overcome cancer? Cowley G Newsweek; 2001; 138(11A):66-9, 71. PubMed ID: 11586855 [No Abstract] [Full Text] [Related]
6. [Modality therapy of patients with non-resectable cancer using cytokines and antineoplastic agents]. Kogo Y; Niitsu Y Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1549-52. PubMed ID: 7528257 [No Abstract] [Full Text] [Related]
10. Increasing options in cancer therapy: current status and future prospects. Georgoulias V; Crown JP Anticancer Drugs; 1999 Nov; 10 Suppl 1():S1-3. PubMed ID: 10630361 [No Abstract] [Full Text] [Related]
11. Melanoma and immunotherapy. Eggermont AM; Schadendorf D Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602 [TBL] [Abstract][Full Text] [Related]
12. Targeting the right treatments for neuroblastoma. Nelson NJ J Natl Cancer Inst; 2011 Aug; 103(16):1218-21. PubMed ID: 21813407 [No Abstract] [Full Text] [Related]
13. Evidence accumulating in support of cancer vaccines combined with chemotherapy: a pragmatic review of past and present efforts. Sinkovics JG; Horvath JC Int J Oncol; 2006 Oct; 29(4):765-77. PubMed ID: 16964374 [TBL] [Abstract][Full Text] [Related]
14. New horizons in treating metastatic disease. Cristofanilli M; Hortobagyi GN Clin Breast Cancer; 2001 Jan; 1(4):276-87. PubMed ID: 11899350 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for prostate cancer - recent progress in clinical trials. Kipp RT; McNeel DG Clin Adv Hematol Oncol; 2007 Jun; 5(6):465-74, 477-9. PubMed ID: 17679921 [TBL] [Abstract][Full Text] [Related]
17. [Combined tumor chemotherapy/gene therapy based on the activation of antineoplastic agents by genetic constructions of cytochromes p450]. Sokolova NN; Iatsenko AN; Pokrovskaia MV Vopr Med Khim; 1999; 45(6):462-71. PubMed ID: 10761211 [TBL] [Abstract][Full Text] [Related]
18. Immunotherapeutics in development for prostate cancer. Harzstark AL; Small EJ Oncologist; 2009 Apr; 14(4):391-8. PubMed ID: 19342474 [TBL] [Abstract][Full Text] [Related]
19. Dendritic cells in cancer immunotherapy. Vulink A; Radford KJ; Melief C; Hart DN Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410 [TBL] [Abstract][Full Text] [Related]
20. Biology and therapy of malignant solid tumors in childhood. van den Berg H Cancer Chemother Biol Response Modif; 2002; 20():605-25. PubMed ID: 12703226 [No Abstract] [Full Text] [Related] [Next] [New Search]